Status | Study |
Recruiting |
Study Name: Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders Condition: Non Malignant Diseases Immunodeficiencies Date: 2010-01-15 Interventions: Drug: RIC: Distal Campath Camp |
Completed |
Study Name: Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies Condition: Hemoglobinopathies Date: 2009-04-21 Interventions: Drug: PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin PEG-IFN alpha2a 180 mcg weekly or PEG-IFN alpha2b |
Suspended |
Study Name: Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies Condition: Anemia, Sickle Cell Complex and Transfusion-dependent Hemoglobinopathi Date: 2008-10-20 Interventions: Biological: Enriched Hematopoetic Stem Cell Infusion Enriched Hematopoetic Stem Cell Infusion |
Recruiting |
Study Name: Bone Marrow for Hemoglobinopathy Research Condition: Sickle Cell Anemia Thalassemia Date: 2008-04-28 |
Terminated |
Study Name: Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP Condition: Sickle Cell Disease Hemoglobin SC Date: 2007-12-19 Interventions: Drug: Busulfan Starting Day -9 |
Completed |
Study Name: Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous Condition: Hgb C Hemoglobinopathy Date: 2007-05-31 Interventions: Procedure: Medical history and basic laboratory analysis Medical history and basic laboratory analysis |
Completed |
Study Name: Invasive Infections in Children With Hemoglobinopathies Condition: Thalassemia Sickle Cell Anemia Date: 2007-04-04 Interventions: Procedure: Historical records |
Completed |
Study Name: A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen Condition: Sickle Cell Disease Thalassemia Hemo Date: 2007-01-18 Interventions: Other: Busulfan; Fludarabine; cyclosporine A and MMF Hematopoietic stem cell transplantation from a matc |
Active, not recruiting |
Study Name: Stem Cell Transplant for Hemoglobinopathy Condition: Sickle Cell Disease Thalassemia Severe Congenital Neutrope Date: 2005-09-12 Interventions: Drug: Busulfan, Fludarabine, ATG, TLI |
Completed |
Study Name: Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies Condition: Hemoglobinopathies Sickle Cell Disease Date: 2005-09-08 Interventions: Drug: Busulfex Given once dail |